Generic drug in Indonesia: why physicians and pharmacists matters
Abstract
Since 2014, Indonesia began imposing the National Health Insurance
program. One of the goals of implementing the program is to increase the use
of generic drugs. This action was done to respond the low use of generic drugs,
which is around 11%, in 2011 (World Bank, 2008). Therefore, this study tried
to examine the factors that influence the purchase intention of generic drugs
based on the information from physicians and pharmacists. Also the overall
information risk with experience was used as moderating variable. The research
sample for this includes 400 respondents. The questionnaires were distributed
from September 2014 until December 2015. The questionnaire distribution
takes a relatively long time due to the very small number of generic drug users
were available. The result shows that physician information have the biggest
effect on the purchase intention of generic drugs, and that experience has a
significant effect as moderating variable